Moderna Inc.MRNA
Sell someDon't buy more at this price.
- 4 good· Earnings beat
- 3 to watch· Thinner margin
$231.76−16.93 (−6.81%)
Price at 3:00 PM ET
After hours · opens in 17h 23mNext open: Friday, Nov 13, 9:30 AM ETNASDAQ · Healthcare · Biotechnology · Large company
Read the full report on MRNA with a free account
The full report adds the whole brief, the scorecard and how the call has moved.A free account gets it on three stocks you pick, plus three long research reports a month.
+778% in a yearsince Nov 11, 2025
Latest results
Reported Friday before the open
- EPS
- $0.38
- vs −$1.25 expected, beat by $1.63 a share
- The stock
- +5.3%
- On Friday, usually 5.3%
Our call is still Sell some after the results.
The news behind our call
written Monday, 5:29 PM ETMonday, 5:29 PM ET · 18 articles · 8 sources
Moderna reported $0.38 of earnings per share versus an expected $1.25 loss.
Analysts expect strong future earnings growth.
What changed
From Yahoo Finance, Moderna Inc. via Yahoo Finance, Seeking Alpha and 2 more
Moderna beat EPS estimates, while oncology expectations and valuation risk remain elevated.
Overview
In plain numbers
- Revenue grew 13.1% from a year earlier, to $2.5B in the last twelve months.
- It loses 81 cents on every revenue dollar at the operating line, down from 72 cents in FY 2021.
- It burned $2.0B of free cash in the last twelve months.
- It holds $8.0B in cash and investments against $4.2B of debt, which leaves $3.7B of net cash.
Key figures
- Revenue (TTM)
- $2.5B
- Revenue growth, 1 year
- +13.1%
- Net income
- −$2.8B
- EPS (diluted)
- −$7.03
- Gross margin
- -42.0%
- Operating margin
- -80.8%
- Return on equity
- -34.5%
- Return on capital
- -46.3%
- Debt / equity
- 0.62
- Current ratio
- 3.62
- Buyback yield
- -2.26%
Key facts
- Company value
- $107B
- Today's range
- 231.32245.37
- Past year's range
- 22.36269.00
- Yesterday's close
- $248.69
- Swings vs the market
- 0.9×about the same